XRAY
16
-3
HAS
42
-6
FCX
47
-2
SO
66
-7
NFLX
61
2
NWL
19
-9
PPL
52
-5
EMN
66
-6
PSX
45
3
MAS
47
-4
MAT
39
-4
VIX
25
-8
OMC
48
-3
WEC
46
-4
AEE
41
-9
PH
62
-2
ICE
64
-3
GLW
61
-2
UPS
40
-8
DGX
29
-4
XRAY
16
-3
HAS
42
-6
FCX
47
-2
SO
66
-7
NFLX
61
2
NWL
19
-9
PPL
52
-5
EMN
66
-6
PSX
45
3
MAS
47
-4
MAT
39
-4
VIX
25
-8
OMC
48
-3
WEC
46
-4
AEE
41
-9
PH
62
-2
ICE
64
-3
GLW
61
-2
UPS
40
-8
DGX
29
-4
Financhill
Back

Canadian Natural Resources Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
41

CNQ
Canadian Natural Resources

Last Price:
35.17
Seasonality Move:
0.33%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
40.42
Seasonality Move:
-0.9%
Sell
41
Canadian Natural Resources (CNQ) is a Sell

Is Canadian Natural Resources a Buy, Sell or Hold?

  • The current Canadian Natural Resources [CNQ] share price is $35.44. The Score for CNQ is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CNQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNQ Stock Price Chart

What is Canadian Natural Resources's stock price today?

  • The Canadian Natural Resources share price today is $35.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNQ is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

CNQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 45.73 Sell
Chaikin Money Flow: -755796 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.74 - 37.84) Sell
Bollinger Bands (100): (33.42 - 39.16) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

CNQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.76 Buy
20-day SMA: 35.82 Sell
50-day SMA: 37.29 Sell
200-day SMA: 34.29 Buy
8-day EMA: 35.1 Buy
20-day EMA: 35.72 Sell
50-day EMA: 36.54 Sell
200-day EMA: 34.55 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Canadian Natural Resources Earnings Growth & CNQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.14 per share, and an increase next year of $0.60 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Canadian Natural Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):